Loading...
Loading...
India's metoprolol imports from AUSTRALIA total $574 across 4 shipments from 1 foreign suppliers. NEWLIFE MEDICALS USA INC leads with $574 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include IPCA LABORATORIES LIMITED. This corridor reflects India's pharmaceutical import demand for metoprolol — a concentrated sourcing relationship with select suppliers from AUSTRALIA.

NEWLIFE MEDICALS USA INC is the leading Metoprolol supplier from AUSTRALIA to India, with import value of $574 across 4 shipments. The top 5 suppliers — NEWLIFE MEDICALS USA INC — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEWLIFE MEDICALS USA INC | $574 | 4 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | IPCA LABORATORIES LIMITED | $574 | 4 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Metoprolol suppliers from AUSTRALIA to India include NEWLIFE MEDICALS USA INC. The leading supplier is NEWLIFE MEDICALS USA INC with import value of $574 USD across 4 shipments. India imported Metoprolol worth $574 USD from AUSTRALIA in total across 4 shipments.
India imported Metoprolol worth $574 USD from AUSTRALIA across 4 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Metoprolol sourced from AUSTRALIA include IPCA LABORATORIES LIMITED. The largest buyer is IPCA LABORATORIES LIMITED with $574 in imports across 4 shipments.
The total value of Metoprolol imports from AUSTRALIA to India is $574 USD, across 4 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists